Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

899 Rezvilutamide
23d625e2965e9a9251a5f0b2204a86618439fc32cbf56996ccfd0508060c05a2

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Rezvilutamide (; developmental code name SHR3680) is a nonsteroidal antiandrogen which is under development by Jiangsu Hengrui Medicine for the treatment of prostate cancer and breast cancer. It is a selective androgen receptor antagonist with reduced brain distribution compared to the structurally related nonsteroidal antiandrogen enzalutamide. As of October 2020, rezvilutamide is in phase 3 clinical trials for prostate cancer. Other structural analogues of rezvilutamide besides enzalutamide include apalutamide and proxalutamide.

From Wikipedia, the free encyclopedia. License: CC BY-SA.